With up to 1% of the World’s population suffering from von Willebrand disease (VWD), it is by far the most common type of bleeding disorder....
Every two years, the WFH recognizes outstanding volunteers who generously share their time, expertise, energy—and deep and longstanding commitment—with the global bleeding disorders community. This...
The following is the first in a 3-part series about how NMOs in the Middle East region have responded to the coronavirus disease 2019 (COVID-19)...
It’s official! Registration for the WFH Virtual Summit: Connecting the Global Bleeding Disorders Community is now open. The Virtual Summit—which is free—will feature a series...
The World Federation of Hemophilia (WFH) is monitoring the manufacturing, safety and supply of hemophilia therapies during the coronavirus pandemic. The WFH will be posting all...
The April 2020 issue of Haemophilia, the official journal of the World Federation of Hemophilia (WFH), includes a section for researchers in developing countries who...
The lack of access to care, clotting factor concentrates and treatment for people affected by a bleeding disorder in developing countries is an urgent and...
For many people with a bleeding disorder, access to care is a considerable daily challenge. The expanded WFH Humanitarian Aid Program aims to address this...
A new article providing additional information on how people with hemophilia (PWH) will be impacted by the COVID‐19 pandemic has been published in Haemophilia, the...
Treatment for people with a bleeding disorder in Kenya has dramatically improved in the last five years. This change was made possible by the collaborative...